DODD 1010.16 CE-01
Technical Procedures for the Military Personnel Drug Abuse Testing Program (MPDATP)
|Publication Date:||27 February 2017|
PURPOSE. This Instruction:
a. Pursuant to DoD Directive (DoDD) 5124.02 (Reference (a)) reissues DoD Instruction (DoDI) 1010.16 (Reference (b)) to update the policies, requirements and procedures for the MPDATP pursuant to DoDI 1010.01 (Reference (c)).
b. Incorporates and cancels Standard Operating Procedures Manual (Reference (d)).
c. Promotes standardization and joint service operations among all Service Forensic Toxicology Drug Testing Laboratories (FTDTL).
APPLICABILITY. This Instruction:
a. Applies to:
(1) OSD, the Military Departments (including the Coast Guard when operating as a service in the Navy), the Office of the Chairman of the Joint Chiefs of Staff and the Joint Staff, the Combatant Commands, the Office of the Inspector General of the Department of Defense, the Defense Agencies, the DoD Field Activities, and all other organizational entities within the DoD (hereinafter referred to collectively as the "DoD Components"). The term "Military Services" as used herein, refers to the Army, Navy, Air Force, Marine Corps, Active and Reserve Components.
(2) Tests conducted under the MPDATP on specimens received by the military FTDTLs.
(3) Foreign nationals employed by DoD or attending U.S. military training schools only as authorized by intergovernmental agreements negotiated on a country-by-country basis.
b. Does not apply to testing by the Armed Forces Medical Examiner System (AFMES) forensic pathology analysis pursuant to DoDI 5154.30 (Reference (e)).